JPRN-jRCT1031230250招募中Unknown
SELECT follow-up study to evaluate Long-term Impact oF anti-obEsity medication(EX9536-4750) - SELECT-LIFE
Okada Takumi0 个研究点目标入组 110 人开始时间: 2023年7月21日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
入选标准
- •1. Randomized into the SELECT clinical trial (EX9536-4388) and has not withdrawn consent, regardless of level of participation, dose achieved or treatment discontinuation.
- •2. Signed SELECT-LIFE consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
排除标准
- •Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
研究者
相似试验
招募中
1 期
A long term follow up study of ATX-101 given by intravenous infusion once every week in patients with advanced solid tumours.Advanced Solid TumorsCancer - Any cancerACTRN12618001112257Therapim Pty Ltd36
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090Retinopathy of prematurityEUCTR2018-003180-54-CZBayer AG102
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090Retinopathy of prematurityEUCTR2018-003180-54-BGBayer AG102
已完成
3 期
An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090ROPretinopathy of prematurityNL-OMON49661Bayer2
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090Retinopathy of prematurityEUCTR2018-003180-54-SKBayer AG102